期刊文献+

重组人白细胞介素11对急性白血病患者诱导化疗后血小板恢复的影响 被引量:10

原文传递
导出
摘要 重组人白细胞介素11(rhIL-11)为一种促血小板生长因子,临床资料显示,在淋巴瘤和其他实体瘤患者化疗过程中,应用rhIL-11治疗可以有效地减轻血小板减少的程度和加速血小板恢复,从而减少患者对血小板输注的需求。但是,迄今为止,应用rhIL—11治疗急性白血病诱导化疗后的血小板减少的临床报道较少。我们对国产注射用IL—11用于急性白血病患者首次诱导化疗后血小板恢复的有效性和安全性进行了评估。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2006年第3期190-192,共3页 Chinese Journal of Hematology
  • 相关文献

参考文献7

  • 1Tepler I,Elias L,Smith JW,et al.A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy.Blood,1996,87:3607-3614.
  • 2Isaacs C,Robert NJ,Bailey FA ,et al.Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin.J Clin Oncol,1997,15:3368-3377.
  • 3Orazi A,Cooper R J,Tong J,et al.Effects of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) on megakaryocytopoiesis in human bone marrow.Exp Hematol,1996,24:1289-1297.
  • 4Du XX,Neben T,Goldman S,et al.Effects of recombinant human interleukin-11 on hematopoietic reconstitution in transplant mice:acceleration of recovery of peripheral blood neutrophils and platelets.Blood,1993,81:27-34.
  • 5Gordon MS.Thrombopoietic activity of recombinant human interleukin 11 in cancer patients receiving chemotherapy.Cancer Chemother Pharmacol,1996,38 Suppl:S96-98.
  • 6Schwertschlag US,Trepicchio WL,Dykstra KH,et al.Hematopoietic,immunomodulatory and epithelial effects of interleukin-11.Leukemia,1999,13 :1307-1315.
  • 7Smith JW 2nd.Tolerability and side effect profile of rhIL-11.Oncology,2000,14(9 Suppl 8) :41-47.

同被引文献83

引证文献10

二级引证文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部